Table 1.
Clinicopathological characteristics | No. of patients | miR-29a expression | P | |
---|---|---|---|---|
High | Low | |||
WHO grade | < 0.05 | |||
I | 7 | 6 | 1 | |
II | 7 | 5 | 2 | |
III | 7 | 3 | 4 | |
IV | 9 | 3 | 6 | |
Age | 0.518 | |||
< 50 | 14 | 8 | 6 | |
≥ 50 | 16 | 9 | 7 | |
Gender | 0.728 | |||
Male | 16 | 8 | 8 | |
Female | 14 | 8 | 6 | |
Location | ||||
Supratentorial | 18 | 10 | 8 | 0.469 |
Infratentorial | 12 | 5 | 7 | |
Tumor size | ||||
< 3 cm | 13 | 7 | 5 | 0.065 |
≥ 3 cm | 17 | 11 | 6 |
The median expression level of lncRNA- was used as the cutoff